XML 23 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Restructuring and Related Charges
 3 Months Ended
Mar. 31, 2017
Restructuring and Related Activities [Abstract]  
Restructuring and Related Charges
5.
Restructuring and Related Charges
In July 2016, the Company's Board of Directors approved a $100.0 million to $125.0 million restructuring program ("the 2016 Mallinckrodt Program") designed to further improve the Company's cost structure as it continues to transform the business. The 2016 Mallinckrodt Program is expected to include actions across both the Specialty Brands and Specialty Generics segments, as well as within corporate functions. There is no specified time period associated with the 2016 Mallinckrodt Program. In addition to the 2016 Mallinckrodt Program, the Company takes certain restructuring actions to generate synergies from its acquisitions.
Net restructuring and related charges within continuing operations by segment are as follows:
 
Three Months Ended
 
March 31,
2017
 
March 25,
2016
Specialty Brands
$
9.2

 
$
8.0

Specialty Generics
7.4

 
0.6

Corporate
2.1

 
1.5

Restructuring and related charges, net
18.7

 
10.1

Less: accelerated depreciation
(1.5
)
 
(1.7
)
Restructuring charges, net
$
17.2

 
$
8.4



Net restructuring and related charges by program within continuing operations are comprised of the following:
 
Three Months Ended
 
March 31,
2017
 
March 25,
2016
2016 Mallinckrodt Program
$
18.7

 
$
—

2013 Mallinckrodt Program
—

 
8.1

Acquisitions
—

 
2.0

Total
18.7

 
10.1

Less: non-cash charges, including accelerated share-based compensation expense
(1.5
)
 
(1.7
)
Total charges expected to be settled in cash
$
17.2

 
$
8.4



The following table summarizes cash activity for restructuring reserves, substantially all of which are related to employee severance and benefits:
 
2016 Mallinckrodt Program
 
2013 Mallinckrodt Program
 
Acquisitions
 
Total
Balance at December 30, 2016
$
9.5

 
$
5.1

 
$
0.2

 
$
14.8

Charges
17.7

 
—

 
—

 
17.7

Changes in estimate
(0.5
)
 
—

 
—

 
(0.5
)
Cash payments
(7.2
)
 
(3.2
)
 
(0.1
)
 
(10.5
)
Balance at March 31, 2017
$
19.5

 
$
1.9

 
$
0.1

 
$
21.5



Net restructuring and related charges, including associated asset impairments, incurred cumulative-to-date related to the 2016 Mallinckrodt Program was as follows:
 
2016 Mallinckrodt Program
Specialty Brands
$
16.4

Specialty Generics
8.7

Corporate
7.1

 
$
32.2


Substantially all of the restructuring reserves were included in accrued and other current liabilities on the Company's unaudited condensed consolidated balance sheets.